{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042286","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2026-09-11T10:10:33+00:00","discovered_at":"2026-09-11T10:15:00.561012+00:00","generated_at":"2026-09-11T10:15:04.530124+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lipocine raises ATM sales agent fee to up to 3.0% under 2024 agreement","bullets":["On Sept 8, 2026, Lipocine and A.G.P./Alliance Global Partners agreed the Sales Agent fee under the April 26, 2024 Sales Agreement will be up to 3.0%.","Fee is subject to adjustment by mutual consent; replaces prior fee terms under the same ATM agreement.","No offering size, proceeds, or timeline disclosed in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042286","json":"https://secwatch.observer/filing/0001493152-26-042286.json","markdown":"https://secwatch.observer/filing/0001493152-26-042286.md","text":"https://secwatch.observer/filing/0001493152-26-042286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/0001493152-26-042286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-11T10:15:04.530124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}